Market Place
Sourcing Support
USV launches heart failure medication at 8rs per 50mg tablet
15 Oct 2024 //
EXPRESSPHARMA
USV Launches Quinidine Sulphate Tablets For heart arrhythmia
26 Sep 2024 //
EXPRESSPHARMA
USV kickstarts dedicated new plant in Baddi, HP
14 Mar 2024 //
MEDICAL DIALOGUES
USV is planning to introduce nutraceuticals for enhanced diabetes care, says MD Prashant Tewari
31 Dec 2023 //
BUSINESS TODAY
USV partners with Biogenomics to launch biosimilar insulin aspart for diabetes in India
08 Nov 2023 //
FINANCIAL EXPRESS
USV Launches Liralin Range for Diverse Group of Type 2 Diabetes Patients
04 Sep 2023 //
MEDICAL DIALOGUES
USV slashes price of diabetes drug Jalra DP by 20 percent
08 Dec 2022 //
MEDICAL DIALOGUES
Baddi drug units feel side effects of virus curbs
23 Apr 2020 //
ECONOMICTIMES
USV in talks with Novartis to buy Jalra Trademark for Rs. 200 Crore
10 Dec 2019 //
ECONOMIC TIMES
USV to invest Rs. 4,000 million in new formulation plant at Vadodara
25 Sep 2019 //
PHARMABIZ
FDA investigators discover key Strides Pharma quality records in shredding room
18 Jul 2019 //
FIERCE PHARMA
USV appoints Lowe Lintas as creative agency for SebaMed
13 Jun 2019 //
EXCHANGE 4MEDIA
USV Pharms` Generic Octreotide Acetate Receives Approval in US
27 Dec 2018 //
FDA
USV North America`s Generic Octreotide Acetate Receives Approval in US
12 Sep 2018 //
FDA
USV sterile injectables plant overcomes issues listed in letter
20 Feb 2018 //
FIERCE PHARMA
USV Private Limited on Health Canada Inspection List
02 May 2017 //
HEALTH CANADA
Anti-diabetic drug cartel issue reaches CCI, Health Ministry
24 Mar 2017 //
ECONOMIC TIMES
USV Limited Receives FDA Warning Letter
22 Mar 2017 //
FDA
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.